News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
45,370 Results
Type
Article (2290)
Company Profile (14)
Press Release (43064)
Multimedia
Podcasts (1)
Webinars (2)
Section
Business (13657)
Career Advice (144)
Deals (2151)
Drug Delivery (13)
Drug Development (2210)
Employer Resources (6)
FDA (636)
Job Trends (1174)
News (18855)
Policy (1225)
Tag
Academia (258)
Accelerated approval (1)
Allergies (3)
Alliances (4880)
ALS (14)
Alzheimer's disease (169)
Antibody-drug conjugate (ADC) (12)
Approvals (667)
Artificial intelligence (111)
Autoimmune disease (3)
Automation (14)
Bankruptcy (20)
Best Places to Work (1025)
Biosimilars (35)
Biotechnology (8)
Breast cancer (35)
Cancer (229)
Cardiovascular disease (13)
Career advice (127)
Career pathing (5)
CAR-T (5)
CDC (4)
Cell therapy (52)
Cervical cancer (1)
Clinical research (1774)
Collaboration (251)
Compensation (12)
Complete response letters (1)
COVID-19 (111)
CRISPR (3)
C-suite (70)
Cystic fibrosis (3)
Data (292)
Denatured (1)
Depression (6)
Diabetes (11)
Diagnostics (862)
Digital health (12)
Diversity, equity & inclusion (1)
Drug discovery (41)
Drug pricing (10)
Drug shortages (2)
Duchenne muscular dystrophy (1)
Earnings (4133)
Editorial (3)
Employer resources (6)
Events (5260)
Executive appointments (81)
FDA (864)
Friedreich's ataxia (1)
Frontotemporal dementia (2)
Funding (98)
Gene editing (9)
Generative AI (5)
Gene therapy (52)
GLP-1 (49)
Government (180)
Guidances (64)
Healthcare (1520)
HIV (6)
Huntington's disease (4)
Immunology and inflammation (4)
Immuno-oncology (5)
Indications (9)
Infectious disease (127)
Inflammatory bowel disease (9)
Inflation Reduction Act (2)
Influenza (8)
Intellectual property (8)
Interviews (21)
IPO (766)
IRA (5)
Job creations (157)
Job search strategy (109)
JPM (3)
Labor market (6)
Layoffs (18)
Leadership (3)
Legal (157)
Liver cancer (7)
Lung cancer (26)
Lymphoma (7)
Machine learning (10)
Management (4)
Manufacturing (158)
MASH (4)
Medical device (951)
Medtech (954)
Mergers & acquisitions (1490)
Metabolic disorders (42)
Multiple sclerosis (14)
Neurodegenerative disease (27)
Neuropsychiatric disorders (4)
Neuroscience (288)
Neurotech (1)
NextGen: Class of 2026 (654)
Non-profit (270)
Now hiring (18)
Obesity (24)
Opinion (20)
Ovarian cancer (3)
Pain (31)
Pancreatic cancer (12)
Parkinson's disease (31)
Partnered (4)
Patents (30)
Patient recruitment (15)
Peanut (2)
People (4154)
Pharmaceutical (5)
Pharmacy benefit managers (1)
Phase 1 (628)
Phase 2 (815)
Phase 3 (518)
Pipeline (373)
Policy (8)
Postmarket research (52)
Preclinical (321)
Press Release (1)
Prostate cancer (10)
Psychedelics (2)
Radiopharmaceuticals (12)
Rare diseases (33)
Real estate (578)
Recruiting (2)
Regulatory (1098)
Reports (8)
Research institute (278)
Resumes & cover letters (16)
RNA editing (1)
RSV (5)
Schizophrenia (10)
Series A (18)
Series B (12)
Service/supplier (2)
Sickle cell disease (4)
Special edition (1)
Spinal muscular atrophy (3)
Sponsored (9)
Startups (233)
Stomach cancer (1)
Supply chain (5)
Vaccines (28)
Venture capital (7)
Weight loss (14)
Women's health (9)
Worklife (1)
Date
Last 7 days (39)
Last 30 days (144)
Last 365 days (2135)
2026 (202)
2025 (2177)
2024 (2599)
2023 (2690)
2022 (4542)
2021 (4217)
2020 (4439)
2019 (4187)
2018 (2954)
2017 (2345)
2016 (2234)
2015 (2250)
2014 (1536)
2013 (1259)
2012 (1430)
2011 (1384)
2010 (1045)
Location
Africa (58)
Alabama (4)
Arizona (10)
Arkansas (1)
Asia (1821)
Australia (351)
California (795)
Canada (210)
China (39)
Colorado (24)
Connecticut (13)
Delaware (12)
Europe (5711)
Florida (72)
Georgia (24)
Idaho (16)
Illinois (82)
India (8)
Indiana (117)
Japan (19)
Kansas (10)
Kentucky (7)
Louisiana (4)
Maine (6)
Maryland (64)
Massachusetts (578)
Michigan (8)
Minnesota (39)
Mississippi (2)
Missouri (17)
Montana (2)
Nebraska (1)
Nevada (8)
New Jersey (207)
New York (167)
North Carolina (157)
Northern California (383)
Ohio (57)
Oklahoma (4)
Oregon (6)
Pennsylvania (117)
Puerto Rico (2)
Rhode Island (2)
South America (76)
South Carolina (3)
Southern California (266)
Tennessee (23)
Texas (186)
United States (2831)
Utah (31)
Virginia (18)
Washington D.C. (6)
Washington State (40)
Wisconsin (15)
45,370 Results for "neural analytics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Kallyope Announces 2026 Strategic Priorities for Migraine and Metabolism Portfolio Based on Novel Neural Circuits Platform
January 7, 2026
·
5 min read
Press Releases
Neural’s Portfolio Company Hanf.com Expands Retail Footprint to Northern Germany with Two New Stores in Bielefeld and Herford
November 6, 2025
·
5 min read
Press Releases
Neural’s Partner Hanf.com Expands Retail Footprint with 17th Store Opening Near Munich
September 23, 2025
·
4 min read
Press Releases
Neural Therapeutics Announces RSU and Options Grant
May 13, 2025
·
5 min read
Business
Neural Therapeutics Announces Changes to Board of Directors and Advisors
Neural Therapeutics Inc. (“Neural” or the “Company”), an ethnobotanical drug discovery company dedicated to developing therapeutic drugs for mental illnesses related to substance use disorders, including alcohol and opioids, wishes to announce that Dr. Kelly Narine and Professor Jason Dyck have resigned as directors of Neural, and Dr. Carlos Davidovich was appointed as a new director.
June 27, 2024
·
5 min read
Press Releases
Neural Announces Completion of the Acquisition of a 30.75% Interest in Hanf.com, a Profitable German CBD Retail Store Chain
August 13, 2025
·
12 min read
Press Releases
Nilo Therapeutics launches with $101 million Series A financing to advance a new class of medicines targeting neural circuits in immune disease and appoints Kim Seth as Chief Executive Officer
October 8, 2025
·
4 min read
Press Releases
Neural Announces Approval of the Strategic Investment and Option Agreement by CWE Shareholders to Acquire up to 100% of CWE
July 22, 2025
·
5 min read
Press Releases
NanoMosaic Secures FDA Advanced Manufacturing Technology (AMT) Designation for Advanced Gene Therapy Analytics
January 29, 2026
·
3 min read
Press Releases
Neural Therapeutics Strengthens IP Portfolio With a Patent Application
Treatment of Major DSM-5 Disorders, Including Addiction, Depression and Anxiety, With Sub-Hallucinogenic Mescaline Doses Extraction Technology Delivering Higher Yields and Greater Purity Frankfurt Stock Exchange Ticker Symbol Changed to “HANF” Extension of LOI with CWE European Holdings (dba Hanf.com)
April 14, 2025
·
7 min read
1 of 4,537
Next
